{
"id":"mk19_a_np_q078",
"number":78,
"bookId":"np",
"correctAnswer":"A",
"title":"Question 78",
"stimulus":[
{
"type":"p",
"hlId":"1aa528",
"children":[
"A 28-year-old woman is evaluated for leg weakness and mild nausea several days after treatment with intravenous ferric carboxymaltose for severe iron deficiency anemia. She has Crohn disease. She reports that her appetite is good. Medications are prednisone, sulfasalazine, infliximab, calcium carbonate, and vitamin D."
]
},
{
"type":"p",
"hlId":"aa0488",
"children":[
"On physical examination, temperature is 37.0 °C (98.6 °F), pulse rate is 80/min, and respiration rate is 16/min. BMI is 18. Abdominal examination reveals tenderness. Motor strength is 4/5 in the hip flexors and extensors. The remainder of the examination is normal."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"89662a",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, serum",
"children":[
"Electrolytes"
]
},
":"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d41d8c",
"class":"cell text l",
"children":[

]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"b99276",
"class":"cell text li",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, Sodium, serum",
"children":[
"Sodium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"1fd2c7",
"class":"cell text l",
"children":[
"136 mEq/L (136 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"e92687",
"class":"cell text li",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, Potassium, serum",
"children":[
"Potassium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"687d76",
"class":"cell text l",
"children":[
"3.8 mEq/L (3.8 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"a207b1",
"class":"cell text li",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, Chloride, serum",
"children":[
"Chloride"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"4fb259",
"class":"cell text l",
"children":[
"108 mEq/L (108 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft2"
},
"children":[
{
"type":"p",
"hlId":"6827e3",
"class":"cell text li",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, Bicarbonate, serum",
"children":[
"Bicarbonate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"9fc245",
"class":"cell text l",
"children":[
"21 mEq/L (21 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"a4922e",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Phosphorus, serum",
"children":[
"Phosphorus"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"be4aca",
"class":"cell text l",
"children":[
"1.2 mg/dL (0.39 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f212ab",
"class":"cell text l",
"children":[
"Fractional excretion of phosphorus"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"ba9c07",
"class":"cell text l",
"children":[
"21%"
]
}
]
}
]
}
]
}
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"6403ae",
"children":[
"Which of the following is the most likely cause of this patient's hypophosphatemia?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Ferric carboxymaltose"
}
},
{
"letter":"B",
"text":{
"__html":"Low phosphorus diet"
}
},
{
"letter":"C",
"text":{
"__html":"Metabolic acidosis"
}
},
{
"letter":"D",
"text":{
"__html":"Prednisone"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"4734c0",
"children":[
"Ferric carboxymaltose, an intravenous iron preparation, has been associated with hypophosphatemia by causing renal phosphate wasting."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"ddbbc0",
"children":[
"The most likely cause of this patient's hypophosphatemia is ferric carboxymaltose (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
"). This parenteral iron solution can be administered in a single dose and thus has been increasingly used to treat individuals with severe iron deficiency that cannot be corrected with oral preparations. However, this medication can result in transient hypophosphatemia. Although most reported cases occur after a patient receives repeated doses, hypophosphatemia has occurred after a single dose. The decrease in serum phosphorus is typically not significant, but for patients with risk factors (e.g., vitamin D deficiency, malnutrition, gastrointestinal disease, or use of medications that bind phosphorus in the gut), severe symptomatic hypophosphatemia has occurred. The mechanism has shown to be secondary to increases in fibroblast growth factor 23 (FGF-23), which cause phosphaturia and a decrease in 1-hydroxylation of vitamin D. Other causes of hypophosphatemia include hungry bone syndrome following parathyroidectomy; refeeding of starved individuals; oncogenic osteomalacia associated with sarcomas that secrete FGF-23; and X-linked hypophosphatemic rickets due to a mutation that causes increased FGF-23. It can also occur following liver resection in a living liver donor."
]
},
{
"type":"p",
"hlId":"d9c6cc",
"children":[
"A low phosphorus diet (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
") is not the cause of this patient's hypophosphatemia. The kidney can reduce phosphorus excretion to very low levels, but only a severely phosphate-restricted diet will decrease the serum phosphorus levels (significantly more frequently in women). In addition, the high fractional excretion of phosphorus identifies renal wasting of phosphorus and excludes poor dietary intake as the cause of her hypophosphatemia."
]
},
{
"type":"p",
"hlId":"a71d82",
"children":[
"This patient's serum bicarbonate level is low, suggesting either metabolic acidosis (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") or compensation for respiratory alkalosis. Because there is no evidence of an increased respiratory rate, the low serum bicarbonate level most likely represents a metabolic acidosis. Although metabolic acidosis and respiratory alkalosis can shift phosphorus into cells, metabolic acidosis has a minimal effect and thus would not be the cause of this patient's hypophosphatemia. Additionally, the elevated fractional excretion of phosphorus eliminates intracellular shift of phosphorus as the cause of her hypophosphatemia."
]
},
{
"type":"p",
"hlId":"0914a6",
"children":[
"Although prednisone (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") can cause muscle breakdown and interfere with vitamin D metabolism, it does not typically cause hypophosphatemia."
]
}
],
"relatedSection":"mk19_a_np_s2_4_1_1",
"objective":{
"__html":"Identify ferric carboxymaltose as the cause of hypophosphatemia."
},
"references":[
[
"Ifie E, Oyibo SO, Joshi H, et al. Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction. Endocrinol Diabetes Metab Case Rep. 2019;2019. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31385673",
"target":"_blank"
},
"children":[
"PMID: 31385673"
]
},
" doi:10.1530/EDM-19-0065"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
"A":75,
"B":10,
"C":10,
"D":5,
"E":0
},
"hlIds":[
"1aa528",
"aa0488",
"a462a3",
"89662a",
"d41d8c",
"b99276",
"1fd2c7",
"e92687",
"687d76",
"a207b1",
"4fb259",
"6827e3",
"9fc245",
"a4922e",
"be4aca",
"f212ab",
"ba9c07",
"6403ae",
"4734c0",
"ddbbc0",
"d9c6cc",
"a71d82",
"0914a6"
]
}